PER
Click for more information
1.22% 8.1¢ percheron therapeutics limited

Ann: New data supports ATL1102s broader clinical potential, page-6

  1. Baremoney
    236 Posts.
    lightbulb Created with Sketch. 59
    clock Created with Sketch.
    24/09/21
    09:39
    Post #: 56315660
    Based on the positive outcomes from the protein analysis reported above, Australian Provisional Patent Application No. 2021903024 was filed 20 September 2021 with claims covering applications of ATL1102in new potential disease settings including diabetic, respiratory and age-related diseases to support the Company’s future commercial and partnering plans for ATL1102.

    Asthma and dementia among others im guessing wow!
    ANP Price at posting: 20.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 17  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.001(1.22%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.0¢ 8.3¢ 8.0¢ $52.59K 651.3K

Buyers (Bids)

No. Vol. Price($)
1 56645 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 109832 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.